Cargando…

Niacin Enhancement for Parkinson’s Disease: An Effectiveness Trial

We previously reported that individuals with Parkinson’s disease (PD) present with lower vitamin B3 levels compared to controls. It may be related to carbidopa interaction, defective tryptophan metabolism, and stresses of night sleep disorder. Vitamin B3 is the energy source for all cells by produci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chong, Raymond, Wakade, Chandramohan, Seamon, Marissa, Giri, Banabihari, Morgan, John, Purohit, Sharad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245760/ https://www.ncbi.nlm.nih.gov/pubmed/34220485 http://dx.doi.org/10.3389/fnagi.2021.667032

Ejemplares similares

Low-Dose Niacin Supplementation Improves Motor Function in US Veterans with Parkinson’s Disease: A Single-Center, Randomized, Placebo-Controlled Trial
por: Wakade, Chandramohan, et al.
Publicado: (2021)

Niacin Ameliorates Neuro-Inflammation in Parkinson’s Disease via GPR109A
por: Giri, Banabihari, et al.
Publicado: (2019)

Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson’s Disease
por: Karunaratne, Tennekoon B., et al.
Publicado: (2020)

Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson’s disease symptoms without side effects
por: Wakade, Chandramohan, et al.
Publicado: (2015)

The dimensionality of fatigue in Parkinson’s disease
por: Chong, Raymond, et al.
Publicado: (2018)

Upregulation of GPR109A in Parkinson’s Disease
por: Wakade, Chandramohan, et al.
Publicado: (2014)

Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?
por: Zeman, Miroslav, et al.
Publicado: (2015)

Niacin in Maize
por: Burkholder, Paul R., et al.
Publicado: (1944)

The Pathological Roles of Ganglioside Metabolism in Alzheimer's Disease: Effects of Gangliosides on Neurogenesis
por: Ariga, Toshio, et al.
Publicado: (2011)

Niacin in patients with chronic kidney disease: Is it effective and safe?
por: Park, Cheol Whee
Publicado: (2013)

Hypophosphatemic effect of niacin extended release in ischemic kidney disease
por: Yasmeen, Ghazala, et al.
Publicado: (2015)

Design and Evaluation of Niacin Microspheres
por: Maravajhala, Vidyavathi, et al.
Publicado: (2009)

Ocular Effects of Niacin: A Review of the Literature
por: Domanico, Daniela, et al.
Publicado: (2015)

Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part II: Novel Niacin Mimetics
por: Goel, Harsh, et al.
Publicado: (2016)

Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part I: Alternative Niacin Regimens
por: Dunbar, Richard L., et al.
Publicado: (2016)

Niacin or Ezetimibe for Patients with, or at Risk of Coronary Heart Disease
por: Guthrie, Robert
Publicado: (2010)

Biomimetic thiamine- and niacin-decorated liposomes for enhanced oral delivery of insulin
por: He, Haisheng, et al.
Publicado: (2018)

The effect of niacin on serum phosphorus levels in dialysis patients
por: Edalat-Nejad, M., et al.
Publicado: (2012)

The mechanism and mitigation of niacin-induced flushing
por: Kamanna, V S, et al.
Publicado: (2009)

Amelioration of bleomycin-induced lung fibrosis in hamsters by dietary supplementation with taurine and niacin: biochemical mechanisms.
por: Giri, S N, et al.
Publicado: (1994)

Effect of niacin monotherapy on high density lipoprotein composition and function
por: Gordon, Scott M., et al.
Publicado: (2020)

Acute Liver Failure Secondary to Niacin Toxicity
por: Ellsworth, Marc A., et al.
Publicado: (2014)

NAD(+) repletion with niacin counteracts cancer cachexia
por: Beltrà, Marc, et al.
Publicado: (2023)

Effects of low-dose niacin on dyslipidemia and serum phosphorus in patients with chronic kidney disease
por: Jin Kang, Hyo, et al.
Publicado: (2013)

Emerging Role of Sirtuin 2 in Parkinson’s Disease
por: Liu, Yumei, et al.
Publicado: (2020)

Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system
por: Rawji, Khalil S., et al.
Publicado: (2020)

Dysfunctional Brain Dynamics of Parkinson's Disease and the Effect of Acute Deep Brain Stimulation
por: Li, Zhibao, et al.
Publicado: (2021)

Effectiveness of niacin supplementation for patients with type 2 diabetes: A meta-analysis of randomized controlled trials
por: Xiang, Dan, et al.
Publicado: (2020)

Effects of Niacin Restriction on Sirtuin and PARP Responses to Photodamage in Human Skin
por: Benavente, Claudia A., et al.
Publicado: (2012)

A randomized pilot study on the effect of niacin on pulmonary arterial pressure
por: McNamara, Martin J., et al.
Publicado: (2015)

Effect of Niacin on Inflammation and Angiogenesis in a Murine Model of Ulcerative Colitis
por: Salem, Hesham Aly, et al.
Publicado: (2017)

The Absence of Adiponectin Alters Niacin’s Effects on Adipose Tissue Inflammation in Mice
por: Graff, Emily C., et al.
Publicado: (2020)

Effects of Niacin on Resistance to Enterotoxigenic Escherichia coli Infection in Weaned Piglets
por: Zhen, Rui, et al.
Publicado: (2022)

Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease
por: Grogan, John P, et al.
Publicado: (2017)

The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903]
por: Mills, Edward, et al.
Publicado: (2003)

Ganglioside Metabolism and Parkinson's Disease
por: Forsayeth, John, et al.
Publicado: (2018)

Does nicotinic acid (niacin) lower blood pressure?
por: Bays, H E, et al.
Publicado: (2009)

Case report of mental disorder induced by niacin deficiency
por: Wang, Wei, et al.
Publicado: (2012)

Statins combined with niacin reduce the risk of peripheral neuropathy
por: LEHRER, STEVEN, et al.
Publicado: (2020)

Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease
por: Ibanez, Laura, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6pi4136ia7639a0dqt2bbaotbh